DRUG SURVIVAL

You have access
Tumor Necrosis Factor Inhibitor Monotherapy Versus Combination Therapy for the Treatment of Psoriatic Arthritis: Combined Analysis of European Biologics Databases
Matthew L. Thomas, Gavin Shaddick, Rachel Charlton, Charlotte Cavill, Richard Holland, Florenzo Iannone, Giovanni Lapadula, Simona Lopriore, Jakub Závada, Michal Uher, Karel Pavelka, Lenka Szczuková, Prodromos Sidiropoulos, Irini Flouri, Alexandros Drosos, Burkhard Möller, Michael J. Nissen, Rüdiger B. Müller, Almut Scherer, Neil McHugh and Alison Nightingale

The Journal of Rheumatology January 1 2021, 48 (1) 48-57; DOI: https://doi.org/10.3899/jrheum.190815
You have access
Longterm Drug Survival of Tumor Necrosis Factor Inhibitors in Patients with Rheumatoid Arthritis
Paul Emery, Bonnie Vlahos, Piotr Szczypa, Mazhar Thakur, Heather E. Jones, John Woolcott, Paul V. Santos Estrella, Catherine Rolland, Allan Gibofsky, Gustavo Citera, Sargunan Sockalingam and Lisa Marshall

The Journal of Rheumatology April 1 2020, 47 (4) 493-501; DOI: https://doi.org/10.3899/jrheum.181398
You have access
Tumor Necrosis Factor-α Inhibition in Ankylosing Spondylitis and Nonradiographic Axial Spondyloarthritis: Treatment Response, Drug Survival, and Patient Outcome
Justine Corli, René-Marc Flipo, Peggy Philippe, Anne Bera-Louville, Hélène Béhal, Cécile Wibaux and Julien Paccou

The Journal of Rheumatology December 1 2015, 42 (12) 2376-2382; DOI: https://doi.org/10.3899/jrheum.150372

Main menu